BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 17367667)

  • 1. Your soul for a pen?
    DeMaria AN
    J Am Coll Cardiol; 2007 Mar; 49(11):1220-2. PubMed ID: 17367667
    [No Abstract]   [Full Text] [Related]  

  • 2. Banning pens and pads misses the main point.
    Terry SF; Burke W
    Am J Bioeth; 2003; 3(3):63-5. PubMed ID: 14594500
    [No Abstract]   [Full Text] [Related]  

  • 3. Doctors and drug companies.
    Lambert LA
    N Engl J Med; 2005 Feb; 352(7):733-4; author reply 733-4. PubMed ID: 15716575
    [No Abstract]   [Full Text] [Related]  

  • 4. Doctors and the drug industry: reader feedback.
    Warrier R; Houghton B
    Am J Med; 2005 Oct; 118(10):1175-6; author reply 1176. PubMed ID: 16194656
    [No Abstract]   [Full Text] [Related]  

  • 5. Drug industry is told to stop gifts to doctors.
    Pear R
    N Y Times Web; 2002 Oct; ():A1, A29. PubMed ID: 12474836
    [No Abstract]   [Full Text] [Related]  

  • 6. The invisible influence of industry inducements.
    Rhodes R; Capozzi JD
    Am J Bioeth; 2003; 3(3):65-7. PubMed ID: 14594501
    [No Abstract]   [Full Text] [Related]  

  • 7. Who pays for the pizza? Redefining the relationships between doctors and drug companies. 1: entanglement.
    Moynihan R
    BMJ; 2003 May; 326(7400):1189-92. PubMed ID: 12775621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The death of common sense.
    Trachtman H
    Am J Bioeth; 2003; 3(3):W31-W32. PubMed ID: 14594484
    [No Abstract]   [Full Text] [Related]  

  • 9. Lunch with Lilly: who pays?
    Strong C
    Am J Bioeth; 2003; 3(3):62-3. PubMed ID: 14594499
    [No Abstract]   [Full Text] [Related]  

  • 10. Pens and other pharmaceutical industry gifts.
    Brody H
    Am J Bioeth; 2003; 3(3):58-60. PubMed ID: 14594497
    [No Abstract]   [Full Text] [Related]  

  • 11. On the need for probity when physicians interact with industry.
    Scott IA
    Intern Med J; 2006 Apr; 36(4):265-9. PubMed ID: 16640747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cheap trinkets, effective marketing: small gifts from drug companies to physicians.
    Brett AS
    Am J Bioeth; 2003; 3(3):52-4. PubMed ID: 14594493
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical practice and pharmaceutical industry: an always difficult relationship].
    Mastai R
    Acta Gastroenterol Latinoam; 2005; 35(4):209-10. PubMed ID: 16496851
    [No Abstract]   [Full Text] [Related]  

  • 14. Fighting graft--it's academic. Medical centers must embrace conflict rules: critics.
    Romano M
    Mod Healthc; 2006 Jan; 36(5):8-10. PubMed ID: 16479773
    [No Abstract]   [Full Text] [Related]  

  • 15. Doctors and the drug industry: reader feedback.
    Nardone DA
    Am J Med; 2005 Oct; 118(10):1176-7; author reply 1177. PubMed ID: 16194658
    [No Abstract]   [Full Text] [Related]  

  • 16. Ethics and the gift.
    Alumbaugh KA
    J Ky Med Assoc; 2003 Jul; 101(7):295. PubMed ID: 12886713
    [No Abstract]   [Full Text] [Related]  

  • 17. Medical students protest perks from drug companies.
    Opar A
    Nat Med; 2006 Oct; 12(10):1104. PubMed ID: 17024192
    [No Abstract]   [Full Text] [Related]  

  • 18. Don't let medicine lose its soul!
    Schroeder SA
    Pharos Alpha Omega Alpha Honor Med Soc; 2004; 67(3):21-4. PubMed ID: 15449887
    [No Abstract]   [Full Text] [Related]  

  • 19. Practicing accountability in professional ethics.
    d'Oronzio JC
    J Clin Ethics; 2002; 13(4):359-66. PubMed ID: 12793330
    [No Abstract]   [Full Text] [Related]  

  • 20. [Strategies for drug promotion].
    Polonuer JL
    Medicina (B Aires); 2005; 65(4):373-6. PubMed ID: 16193722
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.